

05 May 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260504809410/en/Nocion-Therapeutics-Announces-Full-Enrollment-in-Phase-2b-ASPIRE-Study-of-Taplucainium-for-Chronic-Cough

07 Jan 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-01-07/nocion-therapeutics-extends-series-b-financing-to-93-million-to-support-late-stage-development-of-t